Prevalence and determinants of depression in patients with epilepsy during the COVID-19 pandemic

Middle East Current Psychiatry

Table 5 The relationship between depression and epilepsy during the pandemic among the studied group

Variable		N	None (n = 86)		Mild to moderate (n = 61)		Moderately severe to severe (n = 143)		χ²	P
Variable		N	No.	%	No.	%	No.	%	χ²	P
Rate of seizures after COVID-19:	No change	233	86	36.9	40	17.2	107	45.9	32.23	< 0.001**
Rate of seizures after COVID-19:	Increase	57	0	0	21	36.8	36	63.2	32.23	< 0.001**
Rate of ER visits after COVID-19:	No change	109	38	34.9	35	32.1	36	33	21.17	< 0.001**
Rate of ER visits after COVID-19:	Increase	118	48	26.5	26	14.4	107	59.1	21.17	< 0.001**
Drug adherence during the pandemic	No change	212	74	34.7	44	20.9	94	44.4	7.68	0.005*
Drug adherence during the pandemic	Lack	78	12	14.8	22	28.6	44	56.6	7.68	0.005*
Routine follow-up during the pandemic	No change	128	49	38.3	25	19.5	54	42.2	8.35	0.02*
Routine follow-up during the pandemic	Lack	162	37	22.8	36	22.2	89	54.9	8.35	0.02*

χ² chi-square test, NS nonsignificant (P > 0.05); *significant (P < 0.05), **highly significant (P < 0.001)